Welcome to vpod.ai’s The Deep Dive, proudly sponsored by StoneFly. In this episode, we explore the complex, often misunderstood world of neuroendocrine tumors (NETs)—from silent symptoms to cutting-edge treatments revolutionizing outcomes.
You’ll learn:
- What NETs are, where they originate, and why the term “carcinoid” is outdated
- How carcinoid syndrome causes symptoms like flushing, diarrhea, and heart issues
- The step-by-step diagnostic process, from biomarkers to biopsy
- Why surgery remains vital—and what’s next when surgery isn’t enough
- Advances in somatostatin analogs, Everolimus, and targeted therapies
- Game-changers like CAR-T cell therapy, new immunotherapy combinations, and anti-angiogenesis drugs
- How the latest FDA approvals are reshaping care for advanced and aggressive NETs
This is the frontline of rare cancer research—where collaboration, innovation, and precision medicine are making a real difference.
